Stephanie Venn-Watson
Stephanie Venn-Watson
Co-Founder, CEO
Dr. Stephanie Venn-Watson is the Founder/CEO of Seraphina Therapeutics, a veterinary epidemiologist, and an expert in healthy fats essential to supporting healthy aging and longevity. Her groundbreaking discoveries have been featured as a TEDx talk, The New York Times Science article, and NPR’s Science Friday. Stephanie has 80+ peer-reviewed scientific publications and 50+ patents. Over the past 20 years, Stephanie has led perhaps one of the best origin stories ever, culminating in fatty15, an award-winning and science backed C15:0 supplement to support healthy aging.

Dolphins are large brained, long-lived mammals that age similarly to humans, including susceptibilities to chronic inflammation, metabolic and liver diseases, and neurodegenerative conditions. Upon observing that Navy dolphins aged at different rates, Stephanie discovered that the healthiest aging dolphins had the highest dietary and circulating levels of C15:0 (pentadecanoic acid). Stephanie went on to show that C15:0 not only helped to improve dolphins’ health, but that it slowed their aging rates.

Today, C15:0 is recognized as the first essential fatty acid to be discovered since omega-3, which was over 90 years ago. Mounting peer-reviewed scientific publications from prestigious teams throughout the world have demonstrated how C15:0 directly taps into the core of the human longevity pathway, reverses multiple hallmarks of aging, tangibly improves clinically relevant indices, stems chronic aging-associated conditions, and can extend longevity.